Vericel
VCEL
57.52
-0.74
-1.27%
Vericel
US · VCEL
#2759 by market cap
Listed 1970
57.52
-0.74
-1.27%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
TD Cowen Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $58Market Newswire · 2026/7/31
-
Rating change
Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Announces Target Price $54Market Newswire · 2026/7/16
-
Rating change
Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $58Market Newswire · 2026/7/31
-
Rating change
Analysts' Opinions Are Mixed on These Healthcare Stocks: Vericel (VCEL), Sarepta Therapeutics (SRPT) and Neumora Therapeutics, Inc. (NMRA)TipRanks · 2026/7/28
-
Rating change
H.C. Wainwright Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $70Market Newswire · 2026/5/8
-
H.C. Wainwright Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $75Market Newswire · 2026/11/6
-
Rating change
H.C. Wainwright Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $72Market Newswire · 2026/7/31
-
Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $65Market Newswire · 2026/11/7
-
Rating change
Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Announces Target Price $52Market Newswire · 2026/10/14
-
Rating change
TD Cowen Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $58Market Newswire · 2026/9/4
-
Stephens Initiates Vericel(VCEL.US) With Buy Rating, Announces Target Price $68Market Newswire · 2026/11/10
-
Rating change
CCORF Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $58Market Newswire · 2026/6/25
-
Rating change
Truist Financial Maintains Vericel(VCEL.US) With Buy RatingMarket Newswire · 2026/8/20
-
Rating change
H.C. Wainwright Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $64Market Newswire · 2026/2/28
-
Rating change
H.C. Wainwright Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $72Market Newswire · 2026/11/4
-
TD Cowen Maintains Vericel(VCEL.US) With Buy Rating, Raises Target Price to $63Market Newswire · 2026/11/6
-
Rating change
TD Cowen Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $55Market Newswire · 2026/7/29
-
Rating change
H.C. Wainwright Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $70Market Newswire · 2026/7/28
-
BTIG Maintains Vericel(VCEL.US) With Hold RatingMarket Newswire · 2026/11/6
-
Rating change
Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Cuts Target Price to $42Market Newswire · 2026/4/15
-
Rating change
Ladenburg Thalmann & Co. Sticks to Their Buy Rating for Vericel (VCEL)TipRanks · 2026/2/27
-
Rating change
H.C. Wainwright Maintains Vericel(VCEL.US) With Buy Rating, Maintains Target Price $60Market Newswire · 2026/1/20
-
Rating change
Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Announces Target Price $48Market Newswire · 2026/2/27
-
Rating change
Truist Financial Maintains Vericel(VCEL.US) With Buy Rating, Cuts Target Price to $45Market Newswire · 2025/12/18
-
Rating change
Analysts Have Conflicting Sentiments on These Healthcare Companies: BrightSpring Health Services, Inc. (BTSG), Medtronic (MDT) and Vericel (VCEL)TipRanks · 2025/11/20
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Vericel discussion 0 comments